Heights sells subscription plant-based supplements marketed as “braincare,” with customers taking two capsules a day to simplify vitamin routines. Customers complete an initial brain health survey, sign up for monthly/quarterly/annual subscriptions, receive content and coaching, and take a follow-up survey after one month. Heights says its product comes in a letterbox-friendly, Pentagram-designed recyclable bottle and claims 93% of customers improve their brain health score within one month. The company has built an audience via a 60,000-subscriber newsletter and a Braincare podcast with 100,000 downloads, and lists Dr Tara Swart as chief science officer. Its formula emphasizes high-quality, bioavailable nutrients (two capsules deliver 400% of the Nutrient Reference Value of Vitamin D3) and the founders position the brand against quick-fix nootropics by aiming for a daily-care category similar to skincare. Funds from the recent raise will be used for customer growth and new product development, including a soon-to-launch psychobiotic probiotic aimed at cognition and mental health.

Total raised

$2M

Funding rounds

1

Latest round

Seed

Latest activity

Jan 2021